Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.

International guidelines recommend surgical revascularisation for unprotected left main (ULM) coronary artery disease. The introduction of drug-eluting stents (DES) as an emergency therapy has resulted in increasing numbers of patients having stents placed in ULM. As a consequence, important data on...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	De Caterina, A, Cuculi, F, Banning, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
ανά: Porto, I, κ.ά.
Έκδοση: (2005)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
ανά: Chengbin Zheng, κ.ά.
Έκδοση: (2019-01-01)

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
ανά: Schrale, R, κ.ά.
Έκδοση: (2007)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
ανά: Mohammad Saifur Rohman, κ.ά.
Έκδοση: (2023-07-01)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
ανά: Blackman, D, κ.ά.
Έκδοση: (2004)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
ανά: Blackman, D, κ.ά.
Έκδοση: (2003)

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
ανά: Stone, GW, κ.ά.
Έκδοση: (2016)

Paclitaxel eluting stents versus bare metal stents restenosis
ανά: Ronald Aroche Aportela, κ.ά.
Έκδοση: (2021-12-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
ανά: Omar A. Meelu, MS, κ.ά.
Έκδοση: (2017-03-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
ανά: Negar Faramarzi, κ.ά.
Έκδοση: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
ανά: Sohila Refahi, κ.ά.
Έκδοση: (2019-03-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
ανά: Jianbing Zhang, κ.ά.
Έκδοση: (2025-01-01)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
ανά: Birong Liu, κ.ά.
Έκδοση: (2024-12-01)

Risk assessment score for drug eluting stent restenosis
ανά: Z. A. Gabbasov, κ.ά.
Έκδοση: (2018-09-01)

In Stent Restenosis Predictors after Carotid Artery Stenting
ανά: Mirco Cosottini, κ.ά.
Έκδοση: (2010-01-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
ανά: Juan Wang, κ.ά.
Έκδοση: (2025-01-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
ανά: N. G. Veselovskaya, κ.ά.
Έκδοση: (2014-09-01)

Hypersensitivity and in-stent restenosis in coronary stent materials
ανά: Wansong Hu, κ.ά.
Έκδοση: (2022-09-01)

Stents versus bypass grafting for left main coronary artery disease.
ανά: Arnold, JR, κ.ά.
Έκδοση: (2008)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
ανά: Abizaid, A, κ.ά.
Έκδοση: (2012)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
ανά: Mohamed Aboel-Kassem F. Abdelmegid, κ.ά.
Έκδοση: (2017-04-01)

Axial deformation during coronary stenting: an extreme case.
ανά: De Caterina, A, κ.ά.
Έκδοση: (2012)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
ανά: Guillaume Marquis-Gravel, κ.ά.
Έκδοση: (2017-09-01)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
ανά: Xiao-Zeng Wang, κ.ά.
Έκδοση: (2015-01-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
ανά: Kakhaber Etsadashvili, κ.ά.
Έκδοση: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
ανά: Yen-Wen Liu, κ.ά.
Έκδοση: (2021-09-01)

Comparison of Gensini score and SYNTAX score for predicting in-stent restenosis in patients with coronary artery disease and drug-eluting stent implantation
ανά: Min-Tao Gai, κ.ά.
Έκδοση: (2025-01-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
ανά: Yasser Gaber Metwally, κ.ά.
Έκδοση: (2024-12-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
ανά: Wenjie Yang, κ.ά.
Έκδοση: (2025-01-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
ανά: Hongfei Xi, κ.ά.
Έκδοση: (2023-03-01)

Association of G22A variant of Adenosine Deaminase gene with coronary in-stent restenosis in coronary artery patients receiving drug-eluting stent
ανά: Elaheh Moosavi, κ.ά.
Έκδοση: (2020-12-01)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
ανά: Yong Zhu, κ.ά.
Έκδοση: (2021-07-01)

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
ανά: Kyle Murnaghan, κ.ά.
Έκδοση: (2022-01-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
ανά: Alain Guidon, κ.ά.
Έκδοση: (2008-01-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
ανά: Ganesh Paramasivam, κ.ά.
Έκδοση: (2019-11-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
ανά: Luo Y, κ.ά.
Έκδοση: (2022-02-01)

Extensive right coronary artery dissection following cutting balloon treatment of in-stent restenosis.
ανά: Niccoli, G, κ.ά.
Έκδοση: (2002)

Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials.
ανά: Ming-duo Zhang, κ.ά.
Έκδοση: (2014-01-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
ανά: Wen-Juan Xiu, κ.ά.
Έκδοση: (2018-01-01)

Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis
ανά: Lucio Padilla, κ.ά.
Έκδοση: (2024-08-01)